References

Sobriety Success

At Home Drug Withdrawal

Get Instant Access

Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320.

Antonini A, Poewe W (2007) Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. Lancet Neurol 6:826-829.

Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT and 5-HT2 receptors. Neuropsychopharmacology 26:40-52.

Barbano MF, Cador M (2007) Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology (Berl) 191:497-506.

Barbano MF, Le Saux M, Cador M (2009) Involvement of dopamine and opioids in the motivation to eat: influence of palatability, homeostatic state, and behavioral paradigms. Psychopharmacology (Berl) 203:475-487.

B arnes NM, S harp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.

Bickerdike MJ (2003) 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Curr Top Med Chem 3:885-897.

Blundell JE, Rogers PJ, Hill AJ (1985) Behavioral structure and mechanisms of anorexia: calibration of natural and abnormal inhibition of eating. Brain Res Bull 15:371-376.

Bonhaus DW, Weinhardt KK, Taylor M, et al (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621-629.

Borgland SL, Taha SA, Sarti F, et al (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601.

Bubar MJ, Cunningham KA (2006) Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971-1985.

Bubar MJ, Cunningham KA (2007) Distribution of serotonin 5-HT2C receptors in the ventral teg-mental area. Neuroscience 146:286-297.

Bubar MJ, Seitz PK, Thomas ML, et al (2005) Validation of a selective serotonin 5-HT2C receptor antibody for utilization in fluorescence immunohistochemistry studies. Brain Res 1063:105-113.

Burbassi S, Cervo L (2008) Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats. Psychopharmacology (Berl) 196:15-27.

Burmeister JJ, Lungren EM, Kirschner KF, et al (2004) Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 29:660-668.

Burns CM, Chu H, Rueter SM, et al (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387:303-308.

Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218.

Callahan PM, Cunningham KA (1995) Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J Pharmacol Exp Ther 274:1414-1424.

Callahan PM, Appel JB, Cunningham KA (1991) Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology (Berl) 103:50-55.

Carlezon WA, Jr., Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-2995.

Carroll ME, Lac ST, Asencio M, et al (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35:237-244.

Childress AR, Hole AV, Ehrman RN, et al (1993) Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 137:73-95.

Clarke PB, Fu DS, Jakubovic A, et al (1988) Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 246:701-708.

Clifton PG, Lee MD, Dourish CT (2000) Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat. Psychopharmacology (Berl) 152:256-267.

Cornelius JR, Perkins KA, Salloum IM, et al (1999) Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients. J Clin Psychopharmacol 19:183-184.

Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284.

Counotte DS, Spijker S, Van de Burgwal LH, et al (2009) Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology 34:299-306.

Covey LS, Glassman AH, Stetner F, et al (2002) A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry 159:1731-1737.

Crombag HS, Grimm JW, Shaham Y (2002) Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology 27:1006-1015.

Crombag HS, Bossert JM, Koya E, et al (2008) Review. Context-induced relapse to drug seeking: a review. Philos Trans R Soc Lond B Biol Sci 363:3233-3243.

Currie PJ, Coscina DV (1997) Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding. Neuroreport 8:3759-3762.

Dalley JW, Laane K, Pena Y, et al (2005) Attentional and motivational deficits in rats withdrawn from intravenous self-administration of cocaine or heroin. Psychopharmacology (Berl) 182:579-587.

Dalley JW, Theobald DE, Berry D, et al (2005) Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology 30:525-537.

Dalley JW, Mar AC, Economidou D, et al (2008) Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav 90:250-260.

Dalton GL, Lee MD, Kennett GA, et al (2006) Serotonin 1B and 2C receptor interactions in the modulation of feeding behavior in the mouse. Psychopharmacology (Berl) 185:45-57.

Deakin JF (1998) The role of serotonin in panic, anxiety and depression. Int Clin Psychopharmacol 13(suppl 4):S1-S5.

Di Chiara G (2000) Role of dopamine in the behavioral actions of nicotine related to addiction. Eur J Pharmacol 393:295-314.

Di Giovanni G, De Deurwaerdere P, Di Mascio M, et al (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587-597.

Di Giovanni G, Di Matteo V, Di Mascio M, et al (2000) Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35:53-61.

Di Giovanni G, Di Matteo V, La Grutta V, et al (2001) m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:111-116.

Di Giovanni G, Di Matteo V, Pierucci M, et al (2008) Serotonin-dopamine interaction: electrophysiological evidence. Prog Brain Res 172:45-71.

Di Matteo V, Di Giovanni G, Di Mascio M, et al (1998) Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology 37:265-272.

Di Matteo V, Di Giovanni G, Di Mascio M, et al (1999) SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195-1205.

Di Matteo V, Di Giovanni G, Di Mascio M, et al (2000) Biochemical and electrophysiological evidence that Ro 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors. Brain Res 865:85-90.

Di Matteo V, Pierucci M, Esposito E (2004) Selective stimulation of serotonin2C receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418-429.

Di Matteo V, Pierucci M, Di Giovanni G, et al (2007) The neurobiological bases for the pharma-cotherapy of nicotine addiction. Curr Pharm Des 13:1269-1284.

Di Matteo V, Di Giovanni G, Pierucci M, et al (2008) Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Prog Brain Res 172:7-44.

Diergaarde L, Pattij T, Poortvliet I, et al (2008) Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 63:301-308.

Doran N, Spring B, McChargue D, et al (2004) Impulsivity and smoking relapse. Nicotine Tob Res 6:641-647.

Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) 86:197-204.

Dray A, Davies J, Oakley NR, et al (1978) The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioral observations. Brain Res 151:431-442.

Epstein DH, Preston KL, Stewart J, et al (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 189:1-16.

Evenden JL (1999) Varieties of impulsivity. Psychopharmacology (Berl) 146:348-361.

Filip M, Cunningham KA (2002) Serotonin 5-HT2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 71:745-756.

Filip M, Cunningham KA (2003) Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin2C (5-HT2C) receptors in rat prefrontal cortex. J Pharmacol Exp Ther 306:734-743.

Filip M, Bubar MJ, Cunningham KA (2004) Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246-1254.

Fitzgerald LW, Iyer G, Conklin DS, et al (1999) Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21:82S-90S.

Fitzgerald LW, Burn TC, Brown BS, et al (2000) Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57:75-81.

Fletcher PJ (1988) Increased food intake in satiated rats induced by the 5-HT antagonists methy-sergide, metergoline and ritanserin. Psychopharmacology (Berl) 96:237-242.

Fletcher PJ (1995) Effects of combined or separate 5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20s schedule of food reinforcement. Brain Res 675:45-54.

Fletcher PJ, Currie PJ, Chambers JW, et al (1993) Radiofrequency lesions of the PVN fail to modify the effects of serotonergic drugs on food intake. Brain Res 630:1-9.

Fletcher PJ, Korth KM, Chambers JW (1999) Depletion of brain serotonin does not alter d-amphetamine self-administration under a variety of schedule and access conditions. Psychopharmacology (Berl) 146:185-193.

Fletcher PJ, Grottick AJ, Higgins GA (2002) Differential effects of the 5-HT2A receptor antagonist M100907 and the 5-HT2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576-586.

Fletcher PJ, Chintoh AF, Sinyard J, et al (2004) Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29:308-318.

Fletcher PJ, Sinyard J, Higgins GA (2006) The effects of the 5-HT2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology (Berl) 187:515-525.

Fletcher PJ, Tampakeras M, Sinyard J, et al (2007) Opposing effects of 5-HT2A and 5-HT2C receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) 195:223-234.

Fletcher PJ, Rizos Z, Sinyard J, et al (2008) The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33:1402-1412.

Fletcher PJ, Le AD, Higgins GA (2008) Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog Brain Res 172:361-383.

Fletcher PJ, Tampakeras M, Sinyard J, et al (2009) Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behavior in 5-HT2C receptor knockout mice. Neuropharmacology 57:259-267.

Fulton S, Woodside B, Shizgal P (2000) Modulation of brain reward circuitry by leptin. Science 287:125-128.

Geyer MA, Vollenweider FX (2008) Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 29:445-453.

Gobert A, Rivet JM, Lejeune F, et al (2000) Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205-221.

Gray RW, Cooper SJ (1996) D-fenfluramine's effects on normal ingestion assessed with taste reactivity measures. Physiol Behav 59:1129-1135.

Grottick AJ, Fletcher PJ, Higgins GA (2000) Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183-1191.

Grottick AJ, Corrigall WA, Higgins GA (2001) Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology (Berl) 157:292-298.

Gurevich I, Englander MT, Adlersberg M, et al (2002) Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 22:10529-10532.

Halford JC, Wanninayake SC, Blundell JE (1998) Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 61:159-168.

Halford JC, Harrold JA, Boyland EJ, et al (2007) Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 67:27-55.

Harrison AA, Everitt BJ, Robbins TW (1997) Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dop-aminergic mechanisms. Psychopharmacology (Berl) 133:329-342.

Hayashi A, Suzuki M, Sasamata M, et al (2005) Agonist diversity in 5-HT2C receptor-mediated weight control in rats. Psychopharmacology (Berl) 178:241-249.

Hayes DJ, Clements R, Greenshaw AJ (2008) Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. Psych2oCpharmacology (Berl) 203:579-588.

Hayes DJ, Mosher TM, Greenshaw AJ (2009) Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Behav Brain Res 197:323-330.

Hewitt KN, Lee MD, Dourish CT, et al (2002) Serotonin 2C receptor agonists and the behavioral satiety sequence in mice. Pharmacol Biochem Behav 71:691-700.

Higgins GA, Fletcher PJ (2003) Serotonin and drug reward:focus on 5-HT2C receptors. Eur J Pharmacol 480:151-162.

Higgins GA, Enderlin M, Haman M, et al (2003) The 5-HT2A receptor antagonist M100,907 attenuates motor and "impulsive-type" behaviors produced by NMDA receptor antagonism. Psychopharmacology (Berl) 170:309-319.

Hitsman B, Pingitore R, Spring B, et al (1999) Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 67:547-554.

Hoebel BG, Hernandez L, McClelland RC, et al (1988) Dexfenfluramine and feeding reward. Clin Neuropharmacol 11(suppl 1):S72-S85.

Hollander E, Rosen J (2000) Impulsivity. J Psychopharmacol 14:S39-S44.

Howell LL, Byrd LD (1995) Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275:1551-1559.

Hoyer D (1988) Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci 9:89-94.

Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13-23.

Hoyer D, Clarke DE, Fozard JR, et al (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157-203.

Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554.

Hutson PH, Barton CL, Jay M, et al (2000) Activation of mesolimbic dopamine function by phen-cyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioral studies. Neuropharmacology 39:2318-2328.

Invernizzi RW, Pierucci M, Calcagno E, et al (2007) Selective activation of 5-HT2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 144:1523-1535.

Ji SP, Zhang Y, Van Cleemput J, et al (2006) Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med 12:324-329.

Jones BJ, Blackburn TP (2002) The medical benefit of 5-HT research. Pharmacol Biochem Behav 71:555-568.

Kawahara Y, Grimberg A, Teegarden S, et al (2008) Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci 28:12834-12844.

Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56.

Kennett GA, Curzon G (1988) Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) 96:93-100.

Kirkham TC (2009) Cannabinoids and appetite: food craving and food pleasure. Int Rev Psychiatry 21:163-171.

Lam DD, Przydzial MJ, Ridley SH, et al (2008) Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149:1323-1328.

Laviolette SR, Nader K, van der Kooy D (2002) Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 129:17-29.

Le AD, Funk D, Harding S, et al (2008) Intra-median raphe nucleus (MRN) infusions of musci-mol, a GABA-A receptor agonist, reinstate alcohol seeking in rats: role of impulsivity and reward. Psychopharmacology (Berl) 195:605-615.

Leander JD (1987) Fluoxetine suppresses palatability-induced ingestion. Psychopharmacology (Berl) 91:285-287.

Lee B, Tiefenbacher S, Platt DM, et al (2004) Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 29:686-693.

Lee MD, Somerville EM, Kennett GA, et al (2004) Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice. Psychopharmacology (Berl) 176:392-49.

Leggio GM, Cathala A, Moison D, et al (2009) Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens. Neuropharmacology 56:507-513.

Leibowitz SF, Alexander JT (1998) Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44:851-864.

Liu S, Cunningham KA (2006) Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity. Drug Alcohol Depend 81:275-282.

Liu S, Bubar MJ, Lanfranco MF, et al (2007) Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 146:1677-1688.

Loh EA, Roberts DC (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berl) 101:262-266.

Lopez-Alonso VE, Mancilla-Diaz JM, Rito-Domingo M, et al (2007) The effects of 5-HT1A and 5-HT2C receptor agonists on behavioral satiety sequence in rats. Neurosci Lett 416:285-288.

Lyness WH, Friedle NM, Moore KE (1980) Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol Biochem Behav 12:937-941.

Marazziti D, Rossi A, Giannaccini G, et al (1999) Distribution and characterization of [3H]mesulergine binding in human brain postmortem. Eur Neuropsychopharmacol 10:21-26.

Markou A (2008) Review. Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci 363:3159-3168.

Maurel S, Schreiber R, De Vry J (1998) Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat. Behav Pharmacol 9:337-343.

Maurel S, De Vry J, Schreiber R (1999) 5-HT receptor ligands differentially affect operant oral self- administration of ethanol in the rat. Eur J Pharmacol 370:217-223.

Maurel S, De Vry J, De Beun R, et al (1999) 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats. Pharmacol Biochem Behav 62:89-96.

McCreary AC, Cunningham KA (1999) Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology 20:556-564.

McMahon LR, Cunningham KA (2001) Role of 5-HT2A and 5-HT2B/2C receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors. Neuropsychopharmacology 24:319-329.

McMahon LR, Filip M, Cunningham KA (2001) Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Neurosci 21:7781-7787.

Mengod G, Pompeiano M, Martinez-Mir MI, et al (1990) Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524:139-143.

Millan MJ, Marin P, Bockaert J, et al (2008) Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci 29:454-464.

Mitchell SH (2004) Measuring impulsivity and modeling its association with cigarette smoking. Behav Cogn Neurosci Rev 3:261-275.

Moeller FG, Barratt ES, Dougherty DM, et al (2001) Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783-1793.

Naranjo CA, Knoke DM (2001) The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. J Clin Psychiatry 62(suppl 20):18-25.

Naranjo CA, Poulos CX, Bremner KE, et al (1992) Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 51:729-739.

Navailles S, De Deurwaerdere P, Porras G, et al (2004) In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29:319-326.

Navailles S, Moison D, Cunningham KA, et al (2008) Differential regulation of the mesoaccum-bens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 33:237-246.

Navarra R, Comery TA, Graf R, et al (2008) The 5-HT2C receptor agonist WAY 163909 decreases impulsivity in the 5-choice serial reaction time test. Behav Brain Res 188:412-415.

Neill JC, Cooper SJ (1989) Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology (Berl) 97:213-218.

Neisewander JL, Acosta JI (2007) Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 18:791-800.

Niaura R, Spring B, Borrelli B, et al (2002) Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychol 70:887-896.

Nilsson BM (2006) 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents. J Med Chem 49:4023-4034.

Niswender CM, Herrick-Davis K, Dilley GE, et al (2001) RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24:478-491.

Oades RD (2008) Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog Brain Res 172:543-565.

Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230.

Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539-546.

Peltier R, Schenk S (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology (Berl) 110:390-394.

Perkins KA, Lerman C, Coddington SB, et al (2008) Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl) 200:529-544.

Perry JL, Carroll ME (2008) The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 200:1-26.

Perry JL, Larson EB, German JP, et al (2005) Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 178:193-201.

Pettit HO, Ettenberg A, Bloom FE, et al (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine butnot heroinself-administration in rats.Psychopharmacology (Berl) 84:167-173.

Pierucci M, Di Matteo V, Esposito E (2004) Stimulation of serotonin2C receptors blocks the hyper-activation of midbrain dopamine neurons induced by nicotine administration. J Pharmacol Exp Ther 309:109-118.

Porras G, Di Matteo V, Fracasso C, et al (2002) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311-324.

Porrino LJ, Ritz MC, Goodman NL, et al (1989) Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 45:1529-1535.

Pozzi L, Acconcia S, Ceglia I, et al (2002) Stimulation of 5-hydroxytryptamine (5-HT2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J Neurochem 82:93-100.

Prisco S, Pagannone S, Esposito E (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther 271:83-90.

Quarta D, Naylor CG, Stolerman IP (2007) The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination. Psychopharmacology (Berl) 193:391-402.

Redgrave P (1978) Modulation of intracranial self-stimulation behavior by local perfusions of dopamine, noradrenaline and serotonin within the caudate nucleus and nucleus accumbens. Brain Res 155:277-295.

Remington G (2008) Alterations of dopamine and serotonin transmission in schizophrenia. Prog Brain Res 172:117-140.

Richardson NR, Roberts DC (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci 49:833-840.

Robbins TW (2002) The 5-choice serial reaction time task: behavioral pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362-380.

Roberts DC, Koob GF, Klonoff P, et al (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781-787.

Robinson ES, Dalley JW, Theobald DE, et al (2008) Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology 33:2398-2406.

Rocha BA, Goulding EH, O'Dell LE, et al (2002) Enhanced locomotor, reinforcing, and neuro-chemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 22:10039-10045.

Rosenzweig-Lipson S, Zhang J, Mazandarani H, et al (2006) Antiobesity-like effects of the 5-HT2C receptor agonist WAY 161503. Brain Res 1073-1074:240-251.

Rothman RB, Baumann MH, Savage JE, et al (2000) Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other sero-tonergic medications. Circulation 102:2836-2841.

Rowland NE, Robertson K, Lo J, et al (2001) Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats. Psychopharmacology (Berl) 156:108-114. 1B/2C

Schmidt HD, Anderson SM, Famous KR, et al (2005) Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol 526:65-76.

Schreiber R, De Vry J (2002) Role of 5-HT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the rat. Prog Neuropsychopharmacol Biol Psychiatry 26:441-449.

Schwartz DH, McClane S, Hernandez L, et al (1989) Feeding increases extracellular serotonin in the lateral hypothalamus of the rat as measured by microdialysis. Brain Res 479:349-354.

See RE (2005) Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 526:140-146.

Sesack SR, Deutch AY, Roth RH, et al (1989) Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213-242.

Sesack SR, Carr DB, Omelchenko N, et al (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann N Y Acad Sci 1003:36-52.

Shaham Y, Shalev U, Lu L, et al (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168:3-20.

Shepard JD, Bossert JM, Liu SY, et al (2004) The anxiogenic drug yohimbine reinstates metham-phetamine seeking in a rat model of drug relapse. Biol Psychiatry 55:1082-1089.

Smith BM, Smith JM, Tsai JH, et al (2008) Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity. J Med Chem 51:305-313.

Smith SR, Prosser WA, Donahue DJ, et al (2009) Lorcaserin (APD356), a selective 5-HT2C agonist, reduces body weight in obese men and women. Obesity (Silver Spring) 17:494-503.

Somerville EM, Horwood JM, Lee MD, et al (2007) 5-HT2C receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice. Eur J Neurosci 25:3115-3124.

Soubrie P (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behavioral and Brain Sciences 9:319-364.

Spyraki C, Fibiger HC, Phillips AG (1982) Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253:195-203.

Tecott LH, Sun LM, Akana SF, et al (1995) Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374:542-546.

Thomsen WJ, Grottick AJ, Menzaghi F, et al (2008) Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325:577-587.

Thomsen M, Hall FS, Uhl GR, et al (2009) Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 29:1087-1092.

Tomkins DM, Joharchi N, Tampakeras M, et al (2002) An investigation of the role of 5-HT2C receptors in modifying ethanol self-administration behavior. Pharmacol Biochem Behav 71:735-744.

Trinko R, Sears RM, Guarnieri DJ, et al (2007) Neural mechanisms underlying obesity and drug addiction. Physiol Behav 91:499-505.

van der Kooy D, Fibiger HC, Phillips AG (1977) Monoamine involvement in hippocampal self-stimulation. Brain Res 136:119-130.

van Ree JM, Gerrits MA, Vanderschuren LJ (1999) Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 51:341-396.

VanderVeen JW, Cohen LM, Cukrowicz KC, et al (2008) The role of impulsivity on smoking maintenance. Nicotine Tob Res 10:1397-1404.

Vickers SP, Clifton PG, Dourish CT, et al (1999) Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice. Psychopharmacology (Berl) 143:309-314.

Vickers SP, Dourish CT, Kennett GA (2001) Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology 41:200-209.

Volkow ND, Wise RA (2005) How can drug addiction help us understand obesity? Nat Neurosci 8:555-560.

Walsh SL, Cunningham KA (1997) Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology (Berl) 130:41-58.

Ward SJ, Lefever TW, Jackson C, et al (2008) Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharmacol Exp Ther 325:567-576.

Werry TD, Loiacono R, Sexton PM, et al (2008) RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther 119:7-23.

Willins DL, Meltzer HY (1998) Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res 781:291-299.

Winstanley CA, Theobald DE, Dalley JW, et al (2004) 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity:interactions with global 5-HT depletion. Psychopharmacology (Berl) 176:376-385.

Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240.

Wogar MA, Bradshaw CM, Szabadi E (1992) Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxytryptaminergic pathways. Psychopharmacology (Berl) 107:373-378.

Zaniewska M, McCreary AC, Przegalinski E, et al (2007) Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 571:156-165.

Zaniewska M, McCreary AC, Filip M (2009) Interactions of serotonin (5-HT)(2) receptor-targeting ligands and nicotine: Locomotor activity studies in rats. Synapse 63:653-661.

Was this article helpful?

0 0
Drug Addiction

Drug Addiction

If you're wanting to learn about drug addiction... Then this may be the most important letter you'll ever read You Are Going To Get A In Depth Look At One Of The Most Noteworthy Guides On Drug Addiction There Is Available On The Market Today. It Doesn't Matter If You Are Just For The First Time Looking For Answers On Drug Addiction, This Guide Will Get You On The Right Track.

Get My Free Ebook


Post a comment